A Qualitative and Usability Evaluation of Advanced Technologies for Home Upper Limb Neurorehabilitation Post-stroke - Trial NCT06406569
Access comprehensive clinical trial information for NCT06406569 through Pure Global AI's free database. This phase not specified trial is sponsored by Tan Tock Seng Hospital and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Tan Tock Seng Hospital
Timeline & Enrollment
N/A
Jun 01, 2024
Feb 01, 2025
Primary Outcome
Compliance Rates
Summary
Due to limited resources such as the low therapist to patient ratio or high costs associated
 to rehabilitation therapy, providing higher therapy dose to patients after discharge is
 highly challenging. This often results in non-use of the impaired limb as a result of the
 decreased therapy dose, causing partial loss of the functional improvements previously gained
 during early rehabilitation.
 
 In this study, the investigators plan to pilot the HomeRehab Gym concept via the deployment
 of three rehabilitation devices at patients' homes: MyoPanda, H-Man and ReHandyBot.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06406569
Device Trial